Related Experiment Video
Updated: Aug 28, 2025

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
Pyroptosis-based nanotherapeutics: Possible mechanisms for cancer treatment
Veda Muppala1, Batoul Farran2, Ganji Purnachandra Nagaraju1
1Department of Hematology and Oncology, Heersink School of Medicine, The University of Alabama, Birmingham, AL 35294, USA.
Abstract:
Pyroptosis represents an inflammatory cell death form induced by inflammasomes and performed by gasdermins. It is characterized by swelling, pore formation, release of cellular content and the activation of innate immunity leading to inflammation. Hence, pyroptosis contributes to inflammatory conditions like cancer and has emerged as a promising immuno-strategy for treating cancer. The advent of nanotechnology, which overlaps with the discovery of pyroptotic cell death, has enabled the development of nano-based pyroptosis inducing platforms aimed at overcoming resistance to apoptosis and enhancing tumor immunity. In this paper, we will describe the various molecular pathways underlying pyroptosis, such as canonical and non-canonical pyroptosis. We will then explore the advances in the field of pyroptosis-based nanotherapeutics and their future implications.
Insights
Pyroptosis, an inflammatory cell death, offers a novel cancer immunotherapy strategy. Nanotechnology enhances pyroptosis induction, overcoming treatment resistance and boosting anti-tumor immunity.
Area of Science:
- Immunology
- Cell Biology
- Nanomedicine
Background:
- Pyroptosis is an inflammatory form of cell death mediated by inflammasomes and gasdermins.
- It involves cell swelling, pore formation, and release of inflammatory signals, contributing to conditions like cancer.
- Pyroptosis is a promising strategy for cancer immunotherapy due to its inflammatory nature.
Purpose of the Study:
- To describe the molecular pathways of pyroptosis, including canonical and non-canonical routes.
- To explore the advancements in pyroptosis-based nanotherapeutics for cancer treatment.
- To discuss the future implications of pyroptosis-inducing nanomedicines.
Main Methods:
- Review of molecular mechanisms of pyroptosis (canonical and non-canonical pathways).
- Exploration of nanotechnology applications in pyroptosis induction.
- Analysis of current research on pyroptosis-based nanotherapeutics.
Main Results:
- Pyroptosis pathways (canonical and non-canonical) detailed.
- Nanotechnology-based platforms for pyroptosis induction are emerging.
- These nanotherapeutics show potential in overcoming apoptosis resistance and enhancing anti-tumor immunity.
Conclusions:
- Pyroptosis is a key inflammatory cell death pathway with significant therapeutic potential in oncology.
- Nanotechnology offers innovative approaches to harness pyroptosis for cancer treatment.
- Pyroptosis-based nanomedicines represent a promising frontier in cancer immunotherapy.
More Related Videos
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
09:01Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Tumor Immunotherapy